MONTREAL, QUEBEC--(Marketwire - February 05, 2008) - Ambrilia Biopharma Inc. (TSX: AMB) today announced that Dr. Philippe Calais, President and Chief Executive Officer, will present an overview of the Company at the 10th Annual BIO CEO & Investor Conference 2008 to be held in New-York City, NY, February 11-13. This presentation will take place on Tuesday, February 12, at 9:30 a.m. local time, in the New Amsterdam Suite.
